Covered recipient · General Payments record
BETTY J HASWELL
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,176.45
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $305.76 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $87.96 | 6 |
| ABBVIE INC. | $85.45 | 4 |
| PFIZER INC. | $70.43 | 4 |
| Medtronic, Inc. | $18.13 | 1 |
| Amgen Inc. | $16.52 | 1 |
| Acerta Pharma LLC | $13.70 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.30 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107303898 | CMS |
| ABBVIE INC. | $25.61 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107303900 | CMS |
| ABBVIE INC. | $14.09 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107303902 | CMS |
| ABBVIE INC. | $20.45 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107303904 | CMS |
| Amgen Inc. | $16.52 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117574772 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.70 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104220919 | CMS |
| Medtronic, Inc. | $18.13 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116987436 | CMS |
| Novo Nordisk Inc | $14.52 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100500841 | CMS |
| Novo Nordisk Inc | $15.05 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100263598 | CMS |
| Novo Nordisk Inc | $14.49 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100276202 | CMS |
| Novo Nordisk Inc | $14.57 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100267264 | CMS |
| Novo Nordisk Inc | $15.78 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100549484 | CMS |
| Novo Nordisk Inc | $13.55 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100541278 | CMS |
| PFIZER INC. | $17.38 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131562468 | CMS |
| PFIZER INC. | $16.10 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132034049 | CMS |
| PFIZER INC. | $16.00 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131772879 | CMS |
| PFIZER INC. | $20.95 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131858579 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.57 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153616586 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.